Abstract:Introduction Pain can affect people regardless of age, gender or ethnicity. Chronic central neuropathic pain (CCNP) is a debilitating condition that affects populations such as stroke survivors, amputees, spinal cord injury patients and patients with multiple sclerosis, with prevalence rates between 30% and 80%. This condition can be caused by a lesion or disease affecting the somatosensory system. CCNP is notoriously drug resistant, and few effective CCNP treatment or management strategies exist. The emergence of non-invasive brain stimulation and neuromodulation techniques provide novel avenues for managing chronic central neuropathic pain. This scoping review aims to systematically identify the methods and effectiveness of non-invasive brain stimulation techniques for treating and managing chronic central neuropathic pain. Methods and analysis The following databases will be searched systematically: PubMed, EMBASE, Cumulative Index to Nursing and Allied Health Literature (CINAHL), Institute of Electric and Electronic Engineers (IEEE), Association of Computing Machinary (ACM) and Scopus. Additional literature will be identified by searching the reference lists of identified studies. Studies will include reviews and original research in both published and grey literatures. Two reviewers will independently screen identified studies for final inclusion. A quantitative analysis on the intervention type, application and efficacy will be synthesised along with a qualitative analysis to describe the effectiveness of each intervention. Ethics and dissemination No primary data will be collected and hence formal ethics review is not required. The results of the scoping review will be presented at relevant national and international conferences, published in a peer-reviewed journal and provided to the stakeholders with plain language to be posted on their websites. This scoping review will provide a foundation to guide the development of future primary research on non-invasive brain stimulation and CCNP.

An extract of phase II and III trials on recent developments in managing neuropathic pain syndromes: diabetic peripheral neuropathy, trigeminal neuralgia, and postherpetic neuralgia

Non-invasive Brain Stimulation Interventions for Management of Chronic Central Neuropathic Pain: a Scoping Review Protocol

Potential Novel Therapeutic Strategies for Neuropathic Pain

Novel Therapies for the Treatment of Neuropathic Pain: Potential and Pitfalls

Diabetic Peripheral Neuropathy: Emerging Treatments of Neuropathic Pain and Novel Diagnostic Methods

Advances in the interventional management of neuropathic pain

[Therapeutic advances in pharmaceutical treatment of neuropathic pain]

Experimental Drugs for Neuropathic Pain

An overview of the safety and efficacy of LX-9211 in treating neuropathic pain conditions

Bioactive compounds for neuropathic pain: An update on preclinical studies and future perspectives

Oral pharmacotherapeutics for the management of peripheral neuropathic pain conditions - a review of clinical trials

Interventional Therapy for Neuropathic Pain

Combination Drug Therapy for the Management of Chronic Neuropathic Pain

A Systematic Guideline by the ASPN Workgroup on the Evidence, Education, and Treatment Algorithm for Painful Diabetic Neuropathy: SWEET

Cellular and molecular mechanisms driving neuropathic pain: recent advancements and challenges

Future Treatment of Neuropathic Pain in Spinal Cord Injury: The Challenges of Nanomedicine, Supplements or Opportunities?

Central Neuropathic Pain Syndromes: Current and Emerging Pharmacological Strategies

Multifunctional Opioid-Derived Hybrids in Neuropathic Pain: Preclinical Evidence, Ideas and Challenges

Treating neuropathic pain and comorbid affective disorders: Preclinical and clinical evidence

Targeting sensory neuron GPCRs for peripheral neuropathic pain

Pharmacotherapy and noninvasive neurostimulation for neuropathic pain